Capital Performance Advisors’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-877	Closed	-$206K	–	262
2024 Q4	$206K	Buy	877 +437	+99%	+$103K	0.07%	149
2024 Q3	$121K	Buy	+440	New	+$121K	0.04%	169